跳至主要内容
临床试验/EUCTR2018-003592-34-DK
EUCTR2018-003592-34-DK进行中(未招募)1 期

Subcutaneous immunoglobulin in de-novo CIDP(Randomized, parallel study of subcutaneous versus intravenous immunoglobulin in treatment-naïve patients with chronic inflammatory demyelinating polyneuropathy) - SIDEC

Aarhus University Hospital0 个研究点目标入组 60 人开始时间: 2019年3月14日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients diagnosed with typical or pure motor CIDP fulfilling the European Federation of Neurological Societies / Peripheral Nerve Society (EFNS/PNS) clinical and elctrophysiological criteria for definite or propable CIDP
  • Age > 18 and <80 years at inclusion
  • Overall disability sum score (ODSS) > 1
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 50
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • Previous treatment with immmunoglobulin
  • Malignancies
  • Other causes of neuropathy (Diabetes Mellitus)
  • Severe medical diseases
  • Other immunomodulating treatment in the last 6 weeks prior to inclusion
  • Hepatitis B and C or HIV

研究者

发起方
Aarhus University Hospital

相似试验